Table of Contents

Volume 104, Issue 3 (389-544)
Published 1 February 2011

Top

Editorials

That lung cancer incidence falls in ex-smokers: misconceptions 2 Open

J Peto

Br J Cancer 104: 389; doi:10.1038/sj.bjc.6606080

The need for a re-evaluation of best supportive care studies reported to date Open

D C Currow, K Foley, S Y Zafar, J L Wheeler and A P Abernethy

Br J Cancer 104: 390-391; doi:10.1038/sj.bjc.6606081

Top

Minireviews

Targeting BRAF for patients with melanoma Open

H-T Arkenau, R Kefford and G V Long

Br J Cancer 104: 392-398; advance online publication, December 7, 2010; doi:10.1038/sj.bjc.6606030

Challenges and opportunities for converting renal cell carcinoma into a chronic disease with targeted therapies Open

M E Gore and J M G Larkin

Br J Cancer 104: 399-406; doi:10.1038/sj.bjc.6606084

Top

Clinical Studies

A prospective study of chemotherapy-induced febrile neutropenia in the South West London Cancer Network. Interpretation of study results in light of NCAG/NCEPOD findings Open

M Okera, S Chan, U Dernede, J Larkin, S Popat, D Gilbert, L Jones, N Osuji, H Sykes, C Oakley, L Pickering, F Lofts and S Chowdhury

Br J Cancer 104: 407-412; advance online publication, December 21, 2010; doi:10.1038/sj.bjc.6606059

Bleeding events in bevacizumab-treated cancer patients who received full-dose anticoagulation and remained on study Open

N B Leighl, J Bennouna, J Yi, N Moore, J Hambleton and H Hurwitz

Br J Cancer 104: 413-418; advance online publication, January 18, 2011; doi:10.1038/sj.bjc.6606074

How traumatic is breast cancer? Post-traumatic stress symptoms (PTSS) and risk factors for severe PTSS at 3 and 15 months after surgery in a nationwide cohort of Danish women treated for primary breast cancer Open

M O'Connor, S Christensen, A B Jensen, S Møller and R Zachariae

Br J Cancer 104: 419-426; advance online publication, January 11, 2011; doi:10.1038/sj.bjc.6606073

A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer Open

F De Vita, M Orditura, E Martinelli, L Vecchione, R Innocenti, V C Sileni, C Pinto, M Di Maio, A Farella, T Troiani, F Morgillo, V Napolitano, E Ancona, N Di Martino, A Ruol, G Galizia, A Del Genio and F Ciardiello

Br J Cancer 104: 427-432; advance online publication, January 18, 2011; doi:10.1038/sj.bjc.6606093

Delayed-type hypersensitivity in classic Kaposi sarcoma patients and controls Open

R M Valenti, E Amodio, J-M Nam, L Preiss, B I Graubard, N Romano and J J Goedert

Br J Cancer 104: 433-436; advance online publication, January 18, 2011; doi:10.1038/sj.bjc.6606088

Top

Translational Therapeutics

The semisynthetic flavonoid monoHER sensitises human soft tissue sarcoma cells to doxorubicin-induced apoptosis via inhibition of nuclear factor-κB Open

H Jacobs, A Bast, G J Peters, W J F van der Vijgh and G R M M Haenen

Br J Cancer 104: 437-440; advance online publication, January 18, 2011; doi:10.1038/sj.bjc.6606065

Enhanced ZAG production by subcutaneous adipose tissue is linked to weight loss in gastrointestinal cancer patients Open

T Mracek, N A Stephens, D Gao, Y Bao, J A Ross, M Rydén, P Arner, P Trayhurn, K C H Fearon and C Bing

Br J Cancer 104: 441-447; advance online publication, January 18, 2011; doi:10.1038/sj.bjc.6606083

Constitutive androstane receptor agonist CITCO inhibits growth and expansion of brain tumour stem cells Open

S Chakraborty, S Kanakasabai and J J Bright

Br J Cancer 104: 448-459; advance online publication, January 11, 2011; doi:10.1038/sj.bjc.6606064

Top

Molecular Diagnostics

Toll-like receptor 2 is present in the microenvironment of oral squamous cell carcinoma Open

L K Ng, A M Rich, H M Hussaini, W M Thomson, A L Fisher, L S Horne and G J Seymour

Br J Cancer 104: 460-463; advance online publication, December 21, 2010; doi:10.1038/sj.bjc.6606057

Polyclonality of BRAF mutations in primary melanoma and the selection of mutant alleles during progression Open

J Lin, Y Goto, H Murata, K Sakaizawa, A Uchiyama, T Saida and M Takata

Br J Cancer 104: 464-468; advance online publication, January 11, 2011; doi:10.1038/sj.bjc.6606072

CXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells Open

S Amatschek, R Lucas, A Eger, M Pflueger, H Hundsberger, C Knoll, S Grosse-Kracht, W Schuett, F Koszik, D Maurer and C Wiesner

Br J Cancer 104: 469-479; advance online publication, December 21, 2010; doi:10.1038/sj.bjc.6606056

The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue Open

O Oladipo, S Conlon, A O'Grady, C Purcell, C Wilson, P J Maxwell, P G Johnston, M Stevenson, E W Kay, R H Wilson and D J J Waugh

Br J Cancer 104: 480-487; doi:10.1038/sj.bjc.6606055

Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancer Open

J B Baker, D Dutta, D Watson, T Maddala, B M Munneke, S Shak, E K Rowinsky, L-A Xu, C T Harbison, E A Clark, D J Mauro and S Khambata-Ford

Br J Cancer 104: 488-495; advance online publication, January 4, 2011; doi:10.1038/sj.bjc.6606054

CD9P-1 expression correlates with the metastatic status of lung cancer, and a truncated form of CD9P-1, GS-168AT2, inhibits in vivo tumour growth Open

W Guilmain, S Colin, E Legrand, J P Vannier, C Steverlynck, M Bongaerts, M Vasse and S Al-Mahmood

Br J Cancer 104: 496-504; advance online publication, January 4, 2011; doi:10.1038/sj.bjc.6606033

Enhancement of osteoclastogenic activity in osteolytic prostate cancer cells by physical contact with osteoblasts Open

A Shiirevnyamba, T Takahashi, H Shan, H Ogawa, S Yano, H Kanayama, K Izumi and H Uehara

Br J Cancer 104: 505-513; advance online publication, January 4, 2011; doi:10.1038/sj.bjc.6606070

Poly(A) RT–PCR measurement of diagnostic genes in pancreatic juice in pancreatic cancer Open

M Oliveira-Cunha, R J Byers and A K Siriwardena

Br J Cancer 104: 514-519; advance online publication, January 18, 2011; doi:10.1038/sj.bjc.6606047

Top

Epidemiology

Does the association of education with breast cancer replicate within twin pairs? A register-based study on Danish female twins Open

M Madsen, P K Andersen, M Gerster, A-M Nybo Andersen, K Christensen and M Osler

Br J Cancer 104: 520-523; doi:10.1038/sj.bjc.6606090

Dietary patterns and risk of breast cancer Open

L Baglietto, K Krishnan, G Severi, A Hodge, M Brinkman, D R English, C McLean, J L Hopper and G G Giles

Br J Cancer 104: 524-531; advance online publication, December 14, 2010; doi:10.1038/sj.bjc.6606044

Analgesic use during pregnancy and risk of infant leukaemia: A Children's Oncology Group study Open

S Ognjanovic, C Blair, L G Spector, L L Robison, M Roesler and J A Ross

Br J Cancer 104: 532-536; advance online publication, December 14, 2010; doi:10.1038/sj.bjc.6606046

Alcohol consumption and risk of renal cell cancer: the NIH-AARP diet and health study Open

J Q Lew, W-H Chow, A R Hollenbeck, A Schatzkin and Y Park

Br J Cancer 104: 537-541; advance online publication, January 18, 2011; doi:10.1038/sj.bjc.6606089

Top

Letters to the Editor

Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value Open

S Garantziotis

Br J Cancer 104: 542; advance online publication, January 11, 2011; doi:10.1038/sj.bjc.6606068

Reply: Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value Open

A Michlmayr, T Bachleitner-Hofmann, M Bergmann and R Oehler

Br J Cancer 104: 543-544; advance online publication, January 11, 2011; doi:10.1038/sj.bjc.6606069